School of Medicine
Showing 1-3 of 3 Results
Saverio La Francesca
Clinical Assistant Professor, Cardiothoracic Surgery
Bio Clinical Focus
-Organ Perfusion and Preservation.
-Clinical Assistant Professor, Cardiothoracic Surgery. Current
-Asst. Professor of Surgery. Ohio State University. Wexner Medical Center. Columbus-Ohio. 2019 ? 2020
-Staff - Department of Cardiovascular Surgery DeBakey Heart and Vascular Center. Houston, Texas. 2010-2013
-Attending Surgeon - Department of Cardiopulmonary Transplantation. Texas Heart Institute at St. Luke?s Episcopal Hospital. Houston, Texas. 2018- 2010
-President and Chief Medical Officer, Mar 2017 to Oct 2017 Biostage, Inc. (NASDAQ: BSTG)
-Executive Vice-President and Chief Medical Officer, Aug 2015 to Mar 2017 Biostage, Inc. (NASDAQ: BSTG)
-Chief Medical Officer, Apr 2014 to Jul 2015 Biostage, Inc. (NASDAQ: BSTG) (formerly Harvard Apparatus Regenerative Technology,
Assistant Professor of Cardiothoracic Surgery (Adult Cardiac Surgery)
Bio Dr. Anson Lee specializes in the surgical treatment of all heart diseases, including ischemic heart disease, structural heart disease, aortic disease, and arrhythmias. He has practiced cardiothoracic surgery at Stanford since 2015. Dr. Lee has a special interest in the surgical treatment of abnormal heart rhythms and minimally invasive techniques to treat heart disease.
James Longoria, MD
Clinical Associate Professor, Cardiothoracic Surgery
Bio Dr. Longoria is a board-certified, fellowship-trained cardiothoracic surgeon. He is a clinical associate professor in the Department of Cardiothoracic Surgery at Stanford University School of Medicine.
Deeply accomplished in all facets of complex adult cardiothoracic procedures, Dr. Longoria is a high-volume surgeon with more than 20 years of experience and an exceptionally low mortality and complication rate.
Dr. Longoria?s surgical experience includes complex mitral valve and tricuspid valve repair, coronary artery bypass grafting, adult congenital repair, as well as procedures for high risk VAD patients. He performs cardiac transplantation, carotid endarterectomy, and implantation of all FDA-approved mechanical circulatory support devices. Additionally, he performs catheter-based valvular procedures (such as transcatheter aortic valve replacement, or TAVR) and open and video-assisted thoracoscopic surgery (VATS) for pulmonary surgical procedures.
He has an applied interest in atrial fibrillation (AFib) and is a nationally recognized expert in the minimally invasive surgical treatment of Atrial Fibrillation (AFib). Dr. Longoria was issued a method patent from the U.S. Patent and Trademark Office for developing the TTMaze (Totally Thoracoscopic) procedure that is central to the Dual Epicardial Endocardial Persistent (DEEP) AFib clinical trial. Dr. Longoria is a principal investigator of the DEEP Trial and of the Terminate AF Study of surgical ablation devices.
Before joining Stanford, Dr. Longoria was the surgical director of cardiac ablation at a prominent AFib center certified by the Society of Chest Pain Centers. He holds patents for a synthetic chord used to connect tissue and for specialized methods he developed to treat cardiac arrhythmias.
At Stanford, Dr. Longoria brings a commitment to patientcentric, personalized care. He is committed to making the experience of surgery as pleasant as possible for his patients. He is also excited for the opportunity to conduct translational research that utilizes the most advanced technology available, in collaboration with colleagues from other disciplines.
For his outcomes and high patient satisfaction ratings, Dr. Longoria has earned awards and recognition, including being named a Top Doctor of Sacramento by his peers for the last five years in a row. He has also been an honoree of the President?s Award for patient satisfaction by the Sutter Independent Physicians.
Dr. Longoria has published articles on genetic variants associated with atrial fibrillation, thoracoscopic left atrial appendage clipping, radiofrequency ablation, and other topics. His work has appeared in the Journal of Thoracic and Cardiovascular Surgery, Annals of Thoracic Surgery, Journal of the American College of Cardiology, Journal of Cardiovascular Electrophysiology, and elsewhere.
He has made numerous presentations on atrial fibrillation surgery and other topics at conferences including the Annual Meeting of the American Association of Thoracic Surgery, Society of Thoracic Surgeons, and International Society for Heart and Lung Transplantation.
Dr. Longoria is a Fellow of the American College of Surgeons and American College of Cardiology. He is a member of the Society of Thoracic Surgeons, Western Thoracic Surgical Association, the International Society for Minimally Invasive Cardiothoracic Surgery, and the Heart Rhythm Society.